Ganoderic acid X
CAS No. 86377-53-9
Ganoderic acid X ( —— )
产品货号. M31666 CAS No. 86377-53-9
Ganoderic acid X is a potential Mdm2 inhibitor(K(i) = 16nM). It is a potential anticancer drug, inhibits topoisomerases and induces apoptosis of cancer cells.
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 5MG | ¥7980 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称Ganoderic acid X
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述Ganoderic acid X is a potential Mdm2 inhibitor(K(i) = 16nM). It is a potential anticancer drug, inhibits topoisomerases and induces apoptosis of cancer cells.
-
产品描述Ganoderic acid X is a potential Mdm2 inhibitor(K(i) = 16nM). It is a potential anticancer drug, inhibits topoisomerases and induces apoptosis of cancer cells.
-
体外实验——
-
体内实验——
-
同义词——
-
通路Others
-
靶点Other Targets
-
受体——
-
研究领域——
-
适应症——
化学信息
-
CAS Number86377-53-9
-
分子量512.72
-
分子式C32H48O5
-
纯度>98% (HPLC)
-
溶解度——
-
SMILES——
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
产品手册
关联产品
-
H-Val-Pro-Pro-OH TFA
H-Val-Pro-Pro-OH(TFA), a proline peptide derivative from milk, is an ACE inhibitor with IC50 of 9 M.
-
Naxitamab
Naxitamab (Hu3F8) 是一种人源化单克隆抗体,靶向二氮冈糖苷 GD2 (hu3F8)。Naxitamab 可用于神经母细胞瘤、骨肉瘤和其他 GD2 阳性癌症的研究。
-
Feeblin
IRF5-IN-1 (compound C5) 是一种 IRF5 通路特异性抑制剂。IRF5-IN-1 显着减少 IRF5 核转位,而不影响 NF-κB p65 的激活。IRF5-IN-1 通过 SLC15A4 起作用,选择性抑制细胞中 TLR7/8 诱导的 IRF5 反应。
021-51111890
购物车()
sales@molnova.cn

